Business Wire

TX-FLUENCE

10.11.2022 14:31:41 CET | Business Wire | Press release

Share
Fluence Will Attend MJBizCon 2022, Sets Spotlight on Helping Cultivators Weather Current Industry Headwinds

Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, will attend this year’s MJBizCon in Las Vegas, Nevada. Fluence will demonstrate its cutting-edge product line at Expo Hall booth #2927 throughout the three-day event and cannabis solutions architect, Casey Rivero, will lead an on-floor educational session on increasing profit margins Nov. 16.

Fresh off findings that cannabis cultivators are adopting LEDs at an increasingly rapid pace from the co-produced Cannabis Business Times “State of the Cannabis Lighting Market” report, each Fluence fixture featured at MJBizCon 2022 offers growers solutions for achieving even more efficient and productive economies of scale. Fluence will host product demonstrations for its feature-rich lighting technologies in the Expo Hall, including:

  • RAPTR, Fluence's robust and durable high-output top light that's ideal for 1:1 HPS replacement.
  • SPYDR 2h, Fluence’s highest output multi-tier or top light for commercial environments.
  • SPYDR Fang, the ideal LED grow light for the craft cannabis grower.
  • VYNE, an intercanopy lighting solution to increase yield that will make its cannabis show debut at MJBizCon.
  • Wireless Flex Dimming, which replaces dimming cables with wireless control to deliver increased simplicity, flexibility, and cost savings.
  • SHYFT Light Scheduler, the newest solution in Fluence’s product lineup and exclusive to North America, giving growers unprecedented control over configuring precise lighting conditions for increased growing cycles and maximum yield.

“The best way to jump from good to great profit margins is by collaborating with a lighting partner that has deep horticultural experience,” said David Cohen, CEO of Fluence. “The team at Fluence includes horticulture service specialists who can offer unique, data-backed insights into the nuances of lighting to ensure cultivators optimize every step of a grow. MJBizCon is an excellent opportunity to showcase our technical expertise and the many reasons why cannabis cultivators prefer working with us and our products.”

Casey Rivero, a former commercial cultivator and cannabis solutions architect at Fluence, will lead an interactive talk in the Lower Exhibitor Spotlight Theater from 11:45 a.m. to 12:15 p.m. on Wednesday, Nov. 16, 2022. His session, “How Technology Choices Are Future-Proofing Margins for Growers​,” will center on helping growers understand how to leverage advanced cultivation technology to de-risk their facility investments, especially in challenging markets. The session will highlight Fluence research to demonstrate how growers can incorporate innovations in lighting to optimize operational costs and drive revenue.

For more information on Fluence, stop by booth #2927 at MJBizCon 2022 from Nov. 16 through Nov.18, or visit www.fluence.science.

About Fluence

Fluence Bioengineering, Inc. (Fluence) creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. Fluence operates as a business unit within Signify’s Digital Solutions division. For more information about Fluence, visit www.fluence.science.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005124/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SMBC and Toshiba Jointly Develop New Equity Indices Using Advanced Quantum-Driven Technologies28.5.2026 03:00:00 CEST | Press release

Sumitomo Mitsui Banking Corporation (“SMBC”) and Toshiba Corporation (“Toshiba”) today announced the joint development of the SMBC/TOSHIBA Quantum Driven Diversified Japan Equity Index and the SMBC/TOSHIBA Quantum Driven Diversified U.S. Equity Index, new equity indices realized with advanced quantum-driven technologies. Collectively, the indices are referred to as “SMBC/TOSHIBA Quantum Diversified” (the “Indices”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519448161/en/ Toshiba’s Simulated Bifurcation Machine 1. Background and Objectives Equity investment is central to asset management, but it also carries the ever-present risk of abrupt and substantial market fluctuations driven by geopolitical developments, changes in economic policy, and other external factors. In uncertain markets, investors are constantly seeking innovations in risk diversification that can protect their assets from unexpected market shocks. SM

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 202627.5.2026 23:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy demonstrated statistically significant overall survival benefit with an unprecedented seven-month improvement in first-line HER2+ GEAOral presentation at ASCO highlights benefit regardless of PD-L1 status, including in PD-L1 <1% BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be presented in an oral presentation (Rapid Oral Abstract: 4010) at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2026, in Chicago.The HERIZON-GEA-01 clinical trial evaluated ZIIHERA® (zanidatamab) plus chemotherapy, with and without TEVIMBRA® (tislelizumab), compared with the control arm of trastuzumab plus chemotherapy as first-line treatment for advanced/metastatic HER2+ gastroesophageal adenocarcinoma (GEA). Dr. Sun Young Rha, Professor of Medical Oncology at the Yonsei Cancer Center, Yonsei Univ

Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards27.5.2026 17:22:00 CEST | Press release

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental factors which impact allergies, is delighted to announce the recipients of the 2025 edition of its prestigious Science Awards for Allergy. Building on the success of the previous edition, this year’s awards recognise outstanding contributions to allergy research and patient engagement and allocate a total of €100,000 to support these initiatives. Four researchers have been selected by the Board as award recipients, each receiving €25,000 across two categories: Innovation In Treatment Awards Assoc. Professor Alexander Eggel, PhD, Department for Biomedical Research, University of Bern, and Department of Rheumatology and Immunology, University Hospital Bern, Switzerland, recognised for his research: “Improving diagnostic and therapeutic options for allergic patients”; Dr Janice A. Layhadi, PhD, Research Associate, National Heart and Lung Institute, Imperial College

Capchase Secures $200M+, as Demand for Vendor Financing in Enterprise Tech Deals Accelerates27.5.2026 16:00:00 CEST | Press release

As buyers face tighter budgets, Capchase helps technology companies close more deals faster with AI-enabled instant financing Capchase, the leading vendor financing platform for enterprise tech, today announced $200M+ in incremental funding to scale its embedded financing infrastructure globally and deploy more AI-enabled features. The funding, a mix of debt warehouse facilities and equity backed by institutional investors, reflects market validation that vendor financing has become essential infrastructure for enterprise technology companies to sell hardware and software products. As global B2B buyers face tighter budgets and greater scrutiny over large, up-front purchases, financing demand is growing. The Market Shift: Financing as a Growth Lever for B2B Tech Companies The $1.3 trillion vendor financing market has been traditionally dominated by banks and other lenders that utilize multi-thread email chains to manual doc review for underwriting. Capchase replaces those bottlenecks wi

ClickHouse Tops $250M ARR and 4,000 Customers, Launches Claude-Powered Agents at Open House 202627.5.2026 15:00:00 CEST | Press release

Annual run-rate revenue more than tripled year-over-year; new CostBench benchmark shows ClickHouse Cloud at 23x better cost-performance than the nearest cloud data warehouse ClickHouse today opened Open House 2026, its second annual user conference, with a set of announcements that mark one of the company's most active quarters since founding. ClickHouse’s serverless cloud offering has crossed over $250 million in annual run-rate revenue — more than triple a year ago — and added more than 1,000 net new customers since January, bringing its total to 4,000. To meet the demands of AI-era workloads, the company also launched ClickHouse Agents, a fully managed agentic analytics service powered by Anthropic's Claude; published CostBench, an open benchmark comparing the major cloud data warehouses on cost-performance; and introduced House Mates, its first formal partner program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye